ReviewJournal of clinical hypertension (Greenwich, Conn.)2012

The pleiotropic effects of phosphodiesterase 5 inhibitors on function and safety in patients with cardiovascular disease and hypertension.

Steven G Chrysant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.